PAVmed Inc. — Director's Dealing 2023

May 1, 2023

SEC Form 3/A — Form 3/A

Issuer: PAVmed Inc. (PAVM)
CIK: 0001624326
Period of Report: 2022-02-22

Reporting Person: O'Neil Shaun (Chief Operating Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common stock	288954	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee stock option (right to buy)	$1.58	2028-07-23	Common stock (195108)		Direct
Employee stock option (right to buy)	$1	2029-03-06	Common stock (100000)		Direct
Employee stock option (right to buy)	$4.44	2031-03-31	Common stock (75000)		Direct

Footnotes

F1: Includes 225,000 shares of restricted stock granted to the reporting person pursuant to the issuer's long term incentive equity plan.

F2: All options vest as to 1/12 of the shares on the first calendar quarter end after the grant date (i.e., on 9/30/18, 3/31/19 and 6/30/21 for the options expiring on 7/23/28, 3/6/29 and 3/31/31 respectively) and as to an additional 1/12 of the shares on each successive calendar quarter end thereafter.